Stemline Therapeutics, Inc

(NASDAQ:STML)

Latest On Stemline Therapeutics, Inc (STML):

Date/Time Type Description Signal Details
2020-11-13 10:22 ESTNewsEuropean advisory group backs Stemline's Elzonris for rare blood cancerN/A
2020-09-26 14:08 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:20 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:13 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 09:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:57 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-24 12:23 ESTNewsEuropean advisory group thumbs down on Stemline's ElzonrisN/A
2020-07-23 18:33 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 13:44 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:47 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 06:14 ESTFinancialsCompany financials have been released.Neutral
2020-06-11 05:43 ESTAnalyst RatingThe Analyst Target Price has decreased from $13.17 to $11.8.Sell
2020-06-10 13:55 ESTNewsStemline Therapeutics acquired by Menarini GroupN/A
2020-06-10 12:29 ESTInsider TradeKenneth Hoberman has directly acquired 600,000 shares and currently holds 1,374,352 shares.Buy
2020-06-10 12:29 ESTInsider TradeIvan Bergstein has directly acquired 220,000 shares and currently holds 3,024,336 shares.Buy
2020-06-10 12:29 ESTInsider TradeDavid Gionco has directly acquired 45,000 shares and currently holds 327,878 shares.Buy
2020-06-02 05:58 ESTEarnings EstimateAn EPS average of -$0.33 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 05:58 ESTAnalyst RatingThe Analyst Target Price has decreased from $17.64 to $13.17.Neutral
2020-05-27 06:21 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 01:55 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 21:25 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 01:55 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 21:42 ESTInsider TradeRobert Francomano has directly disposed of 272 shares and currently holds 197,658 shares.Sell
2020-05-06 16:51 ESTNewsStemline rockets 151% premarket on Menarini bidN/A
2020-05-06 06:28 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 05:52 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:10 ESTInsider TradeIvan Bergstein has directly disposed of 53,618 shares and currently holds 2,804,336 shares.Sell
2020-04-12 15:27 ESTNewsStemline Therapeutics EPS misses by $0.03, revenue in-lineN/A
2020-04-03 21:57 ESTInsider TradeDavid Gionco has directly disposed of 11,524 shares and currently holds 282,878 shares.Sell
2020-04-03 21:55 ESTFinancialsCompany financials have been released.Neutral
2020-03-30 05:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.79 to $17.64.Neutral
2020-03-25 21:32 ESTFinancialsCompany financials have been released.Neutral
2020-03-24 21:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $19.64 to $18.79.Neutral
2020-03-20 21:41 ESTInsider TradeDavid Gionco has directly disposed of 2,849 shares and currently holds 316,885 shares.Sell
2020-03-19 05:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.57 to $19.64.Neutral
2020-03-18 05:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $23.57 to $20.57.Neutral
2020-03-17 17:32 ESTNewsStemline Therapeutics (STML) Investor Presentation - SlideshowN/A
2020-03-17 01:51 ESTFinancialsCompany financials have been released.Neutral
2020-03-16 15:46 ESTNewsStemline Therapeutics, Inc. (STML) CEO Ivan Bergstein on Q4 2019 Results - Earnings Call TranscriptN/A
2020-03-16 05:35 ESTEarnings EstimateAn EPS average of -$0.48 is estimated for the 2021 year.Sell
2020-03-16 05:35 ESTEarnings EstimateAn EPS average of -$0.29 is estimated for the quarter ending on June 30, 2020.Buy
2020-03-13 21:42 ESTInsider TradeDavid Gionco has directly disposed of 8,846 shares and currently holds 319,734 shares.Sell
2020-03-13 21:42 ESTInsider TradeDavid Gionco has directly disposed of 5,011 shares and currently holds 328,580 shares.Sell
2020-03-13 21:42 ESTInsider TradeIvan Bergstein has directly disposed of 20,909 shares and currently holds 2,894,496 shares.Sell
2020-03-13 21:42 ESTInsider TradeIvan Bergstein has directly disposed of 36,542 shares and currently holds 2,857,954 shares.Sell
2020-03-13 21:42 ESTInsider TradeRobert Francomano has directly disposed of 1,266 shares and currently holds 197,930 shares.Sell

About Stemline Therapeutics, Inc (STML):

Stemline Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of oncology therapeutics in the United States and Europe. The company offers ELZONRIS, a targeted therapy directed to the interleukin-3 receptor (CD123) for patients with blastic plasmacytoid dendritic cell neoplasm in adults, and in pediatric patients two years and older. It also developing CD123 that is in Phase I/II clinical trials for the treatment of chronic myelomonocytic leukemia and myelofibrosis, as well as acute myeloid leukemia and multiple myeloma in combination with other therapies. In addition, the company is developing SL-801, a novel oral small molecule reversible inhibitor of nuclear transport protein, which is in Phase I clinical trial for the treatment of solid and hematologic cancers; and SL-701, an immunotherapy that has completed Phase II clinical trials to treat brain cancer. Its preclinical pipeline products include SL-501, a CD123 targeted therapy; SL- 1001, an oral, selective small molecule RET kinase inhibitor targeting multiple oncology indications; and SL-901, a small molecule kinase inhibitor. Stemline Therapeutics, Inc. was founded in 2003 and is headquartered in New York, New York.

STML Quotes by TradingView

See Advanced Chart

General

  • Name Stemline Therapeutics, Inc
  • Symbol STML
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 100
  • Fiscal Year EndDecember
  • IPO Date2013-01-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.stemline.com
View More

Valuation

  • Forward PE 17.92
  • Price/Sales (Trailing 12 Mt.) 11.22
  • Price/Book (Most Recent Quarter) 4.21
  • Enterprise Value Revenue 10.01
View More

Financials

  • Most Recent Quarter 2020-03-31
  • Current Year EPS Estimate -$1.28
  • Next Year EPS Estimate -$0.79
  • Profit Margin -150%
  • Operating Margin -156%
  • Return on Assets -30%
  • Return on Equity -55%
  • Revenue 47.04 million
  • Earnings Per Share -$2.71
  • Revenue Per Share $1.05
  • Gross Profit -12400888
  • Quarterly Earnings Growth 75.7%
View More

Highlights

  • Market Capitalization 621.2 million
  • EBITDA -93657856
  • Analyst Target Price $11.8
  • Book Value Per Share $3.07
View More

Share Statistics

  • Shares Outstanding 52.51 million
  • Shares Float 37.29 million
  • % Held by Insiders 1005%
  • % Held by Institutions 82.43%
  • Shares Short 3.28 million
  • Shares Short Prior Month 5.13 million
  • Short Ratio 1.13
  • Short % of Float 7%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 1.74
  • 52 Week High $12.35
  • 52 Week Low $3.43
  • 50 Day Moving Average 11.89
  • 200 Day Moving Average 7.7
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

Stemline Therapeutics, Inc (STML) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Stemline Therapeutics, Inc (STML) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-03-312020-05-11$8.87 million-$0.45-$0.36-25%
2019-12-312020-03-16$11.83 million-$0.38-$0.35-8.57%
2019-09-302019-11-08$13.33 million-$0.34-$0.4524.44%
2019-06-302019-08-02$13.01 million-$0.42-$0.5625%
2019-03-312019-05-08$5.05 million-$0.73-$0.63-15.87%
2018-12-312019-03-18$500000-$0.92-$0.74-23.74%
2018-09-302018-11-09$-500000-$0.73-$0.67-8.24%
2018-06-302018-08-09$500000-$0.66-$0.64-3.53%
2018-03-312018-05-10$N/A-$0.69-$0.690.58%
2017-12-312018-03-16$599199-$0.92-$0.70-32.11%
2017-09-302017-11-10$299000-$0.68-$0.59-15.98%
2017-06-302017-08-08$300000-$0.66-$0.48-37.54%
2017-03-312017-05-11$299000-$0.67-$0.47-42.09%
2016-12-312017-03-17$299000-$0.56-$0.55-1.75%
2016-09-302016-11-08$299000-$0.56-$0.54-3.06%
2016-06-302016-08-04$237000-$0.52-$0.554.71%
2016-03-312016-05-09$206000-$0.51
2015-12-312016-03-14$205000-$0.58
2015-09-302015-11-06$206000-$0.53
2015-06-302015-08-11$122000-$0.58
2015-03-312015-05-11$121000-$0.46
2014-12-312015-03-16$121000-$0.53
2014-09-302014-11-12$72000-$0.53
2014-06-302014-08-14$71000-$0.47
2014-03-312014-05-15$71000-$0.70
2013-12-312014-02-26$71000-$0.60
2013-09-302013-11-12$N/A-$0.45
2013-06-302013-08-14$N/A-$0.55
2013-03-312013-05-14$N/A-$0.90

Stemline Therapeutics, Inc (STML) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019
Research Development 11.54 million N/A N/A N/A 16.95 million
Income Before Tax -21.26 million -17.64 million -14.88 million -16.86 million -27.41 million
Selling General Administrative 18.54 million 16.48 million 15.41 million 19 million 15.95 million
Gross Profit 8.23 million -1.87 million -71301 1.53 million -11.99 million
Ebit -21.21 million -18.35 million -15.48 million -17.47 million -27.94 million
Operating Income -21.85 million -18.35 million -15.48 million -17.47 million -27.94 million
Income Tax Expense N/A 39021 8747 -18500 -3694
Total Revenue 8.87 million 11.83 million 13.33 million 13.01 million 5.05 million
Cost of Revenue 640986 13.7 million 13.4 million 11.47 million 17.04 million
Total Other Income Expense Net -14808 706248 605224 610430 533968
Net Income From Continuing Operations -21.29 million -17.68 million -14.89 million -16.84 million -27.41 million
Net Income Applicable to Common Shares -21.29 million -17.68 million -14.89 million -16.84 million -27.41 million
Cash Flow:
Date Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019
Investments N/A N/A N/A 13.83 million -49.55 million
Change to Liabilities N/A N/A N/A 335937 4.26 million
Total Cash Flow from Investing Activities 29.25 million N/A N/A 13.83 million -49.63 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 215380 N/A N/A 303869 86.34 million
Change to Operating Activities N/A N/A N/A -457897 -185050
Change in Cash 15.67 million N/A N/A -7.05 million 14.57 million
Total Cash from Operating Activities -13.77 million N/A N/A -21.19 million -22.14 million
Depreciation 14040 N/A N/A 34669 23510
Other Cash Flow from Investing Activities 29.27 million N/A N/A N/A N/A
Change to Inventory N/A N/A N/A -2.81 million -848493
Change to Account Receivables N/A N/A N/A -9.47 million -5.62 million
Other Cash Flow from Financing Activities N/A N/A N/A N/A 102566
Change to Net Income N/A N/A N/A 8.02 million 7.64 million
Capital Expenditures 14520 N/A N/A N/A 74495
Balance Sheet:
Date Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019
Total Liabailities 22.96 million 23.36 million 22.73 million 27.36 million 27.27 million
Total Stockholder Equity 147.65 million 163.62 million 175.43 million 100.79 million 108.89 million
Other Current Liabilities N/A 10125 10000 1.12 million 654147
Total Assets 170.61 million 186.98 million 198.17 million 128.15 million 136.17 million
Common Stock 5250 5035 5001 4388 4358
Other Current Assets N/A N/A N/A N/A 3.12 million
Retained Earnings -387.2 million -365.91 million -348.23 million -333.34 million -316.5 million
Other Liabilities N/A N/A 6949 N/A 12011
Other Assets 293470 308751 212305 212305 212305
Cash 29.23 million 13.56 million 27.38 million 16.97 million 24.01 million
Total Current Liabilities 22.76 million 23.13 million 22.45 million 26.8 million 26.44 million
Other Stockholder Equity N/A 28171 -1724 52488 -27161
Property, Plant & Equipment 1.25 million 1.51 million 1.45 million 1.71 million 2.01 million
Total Current Assets 169.07 million 185.16 million 196.5 million 126.23 million 133.94 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets N/A 163.62 million 175.43 million 100.79 million 108.89 million
Short Term Investments N/A 150.87 million 147.15 million 87.41 million 100.53 million
Long Term Debt N/A N/A N/A N/A 818303
Inventory 1.39 million 1.15 million 2.86 million 3.66 million 848493
Accounts Payable N/A 21.95 million 21.38 million N/A 25.41 million

Stemline Therapeutics, Inc (STML) Chart:

Stemline Therapeutics, Inc (STML) News:

Below you will find a list of latest news for Stemline Therapeutics, Inc (STML) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Stemline Therapeutics, Inc (STML) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Stemline Therapeutics, Inc (STML) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-2215-12BSecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1264587/000110465920075492/0001104659-20-075492-index.htm
2019-03-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1264587/000000000019005584/0000000000-19-005584-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000021545719006857/0000215457-19-006857-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000031506618002158/0000315066-18-002158-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000031506619001352/0000315066-19-001352-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000083423720006933/0000834237-20-006933-index.htm
2020-05-04SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1264587/000089534520000606/0000895345-20-000606-index.htm
2020-05-05SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1264587/000089534520000618/0000895345-20-000618-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000090266419000933/0000902664-19-000933-index.htm
2019-02-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000090266419001279/0000902664-19-001279-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000090266420000952/0000902664-20-000952-index.htm
2019-01-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1264587/000104746919000127/0001047469-19-000127-index.htm
2019-01-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1264587/000104746919000144/0001047469-19-000144-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1264587/000104746920002716/0001047469-20-002716-index.htm
2020-05-12SC 14D9Solicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000104746920003012/0001047469-20-003012-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000108514619000749/0001085146-19-000749-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1264587/000110465918028136/0001104659-18-028136-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918031965/0001104659-18-031965-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465918032190/0001104659-18-032190-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041812/0001104659-18-041812-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041867/0001104659-18-041867-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041868/0001104659-18-041868-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041869/0001104659-18-041869-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041870/0001104659-18-041870-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041871/0001104659-18-041871-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918041872/0001104659-18-041872-index.htm
2018-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918042159/0001104659-18-042159-index.htm
2018-07-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918043575/0001104659-18-043575-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918050940/0001104659-18-050940-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465918050944/0001104659-18-050944-index.htm
2018-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918051312/0001104659-18-051312-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918056985/0001104659-18-056985-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918056986/0001104659-18-056986-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918066967/0001104659-18-066967-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465918066974/0001104659-18-066974-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465918070899/0001104659-18-070899-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465918074472/0001104659-18-074472-index.htm
2019-01-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919001650/0001104659-19-001650-index.htm
2019-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919002118/0001104659-19-002118-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919006896/0001104659-19-006896-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919006897/0001104659-19-006897-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919006898/0001104659-19-006898-index.htm
2019-02-085Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919006899/0001104659-19-006899-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919006900/0001104659-19-006900-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919009112/0001104659-19-009112-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919011256/0001104659-19-011256-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919011257/0001104659-19-011257-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919011258/0001104659-19-011258-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919013682/0001104659-19-013682-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919013683/0001104659-19-013683-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919013684/0001104659-19-013684-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919015288/0001104659-19-015288-index.htm
2019-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1264587/000110465919015293/0001104659-19-015293-index.htm
2019-03-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1264587/000110465919015318/0001104659-19-015318-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919015343/0001104659-19-015343-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919015344/0001104659-19-015344-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919015345/0001104659-19-015345-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919022632/0001104659-19-022632-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919024280/0001104659-19-024280-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919025382/0001104659-19-025382-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1264587/000110465919025384/0001104659-19-025384-index.htm
2019-04-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1264587/000110465919025397/0001104659-19-025397-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919028428/0001104659-19-028428-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465919028623/0001104659-19-028623-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919030357/0001104659-19-030357-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919030358/0001104659-19-030358-index.htm
2019-06-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1264587/000110465919034813/0001104659-19-034813-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038280/0001104659-19-038280-index.htm
2019-06-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038296/0001104659-19-038296-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038302/0001104659-19-038302-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038303/0001104659-19-038303-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038305/0001104659-19-038305-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038306/0001104659-19-038306-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038307/0001104659-19-038307-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038308/0001104659-19-038308-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038309/0001104659-19-038309-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/0001104659-19-038310-index.htm
2019-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919043543/0001104659-19-043543-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465919044314/0001104659-19-044314-index.htm
2019-08-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1264587/000110465919044678/0001104659-19-044678-index.htm
2019-08-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1264587/000110465919045072/0001104659-19-045072-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919045073/0001104659-19-045073-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919046425/0001104659-19-046425-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465919061232/0001104659-19-061232-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465919062655/0001104659-19-062655-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919070016/0001104659-19-070016-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919070740/0001104659-19-070740-index.htm
2019-12-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465919075665/0001104659-19-075665-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920000976/0001104659-20-000976-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920000978/0001104659-20-000978-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920000979/0001104659-20-000979-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/0001104659-20-000980-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920003149/0001104659-20-003149-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920006882/0001104659-20-006882-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920020854/0001104659-20-020854-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022137/0001104659-20-022137-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022138/0001104659-20-022138-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022139/0001104659-20-022139-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022140/0001104659-20-022140-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022141/0001104659-20-022141-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022142/0001104659-20-022142-index.htm
2020-02-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920022143/0001104659-20-022143-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920027397/0001104659-20-027397-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920027398/0001104659-20-027398-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920027399/0001104659-20-027399-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465920033250/0001104659-20-033250-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920033488/0001104659-20-033488-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920033489/0001104659-20-033489-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920033490/0001104659-20-033490-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920033491/0001104659-20-033491-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1264587/000110465920034154/0001104659-20-034154-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920037012/0001104659-20-037012-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920043324/0001104659-20-043324-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920048399/0001104659-20-048399-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920053577/0001104659-20-053577-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465920055854/0001104659-20-055854-index.htm
2020-05-04SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920056147/0001104659-20-056147-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920057631/0001104659-20-057631-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1264587/000110465920059604/0001104659-20-059604-index.htm
2020-05-12SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920060108/0001104659-20-060108-index.htm
2020-05-13SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1264587/000110465920060709/0001104659-20-060709-index.htm
2020-05-15SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920062442/0001104659-20-062442-index.htm
2020-05-15SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920062461/0001104659-20-062461-index.htm
2020-05-19SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920063623/0001104659-20-063623-index.htm
2020-05-21SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920064639/0001104659-20-064639-index.htm
2020-05-27SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920066497/0001104659-20-066497-index.htm
2020-06-01SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920067976/0001104659-20-067976-index.htm
2020-06-02SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920068674/0001104659-20-068674-index.htm
2020-06-02SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920068691/0001104659-20-068691-index.htm
2020-06-04SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920069868/0001104659-20-069868-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071766/0001104659-20-071766-index.htm
2020-06-10SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071780/0001104659-20-071780-index.htm
2020-06-10SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071781/0001104659-20-071781-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071825/0001104659-20-071825-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071826/0001104659-20-071826-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071831/0001104659-20-071831-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071832/0001104659-20-071832-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071835/0001104659-20-071835-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071836/0001104659-20-071836-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071837/0001104659-20-071837-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071838/0001104659-20-071838-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071839/0001104659-20-071839-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071841/0001104659-20-071841-index.htm
2020-06-10POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071855/0001104659-20-071855-index.htm
2020-06-10POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071856/0001104659-20-071856-index.htm
2020-06-10POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071858/0001104659-20-071858-index.htm
2020-06-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071863/0001104659-20-071863-index.htm
2020-06-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071864/0001104659-20-071864-index.htm
2020-06-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071865/0001104659-20-071865-index.htm
2020-06-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071872/0001104659-20-071872-index.htm
2020-06-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071875/0001104659-20-071875-index.htm
2020-06-10S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1264587/000110465920071879/0001104659-20-071879-index.htm
2020-06-2215-12BSecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1264587/000110465920075492/0001104659-20-075492-index.htm
2019-06-11PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1264587/000114036119010820/0001140361-19-010820-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000114544320000103/0001145443-20-000103-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000117266119000630/0001172661-19-000630-index.htm
2020-06-1025-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1264587/000135445720000244/0001354457-20-000244-index.htm
2020-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1264587/000158064220000508/0001580642-20-000508-index.htm
2019-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1264587/999999999519000974/9999999995-19-000974-index.htm
2020-06-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1264587/999999999520001437/9999999995-20-001437-index.htm
2020-06-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1264587/999999999520001438/9999999995-20-001438-index.htm
2020-06-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1264587/999999999520001439/9999999995-20-001439-index.htm

Stemline Therapeutics, Inc (STML) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stemline Therapeutics, Inc (STML). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1005%
Institutional Ownership: 8243%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-23Robert FrancomanoChief Commercial OfficerSell249.0010.582,634.42100,742.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000976/0001104659-20-000976-index.htm
2020-06-10Kenneth HobermanChief Operating OfficerBuy600,000.001,374,352.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920071835/0001104659-20-071835-index.htm
2018-12-21David GioncoChief Accounting OfficerBuy15,000.00170,345.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006896/0001104659-19-006896-index.htm
2020-05-04Robert FrancomanoChief Commercial OfficerSell272.0011.513,130.72197,658.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920057631/0001104659-20-057631-index.htm
2020-03-09Robert FrancomanoChief Commercial OfficerSell1,266.005.006,330.00197,930.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033490/0001104659-20-033490-index.htm
2020-02-10Robert FrancomanoChief Commercial OfficerBuy105,939.00199,196.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920022139/0001104659-20-022139-index.htm
2018-06-21DANIEL HUMEDirectorBuy20,468.0020,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918041870/0001104659-18-041870-index.htm
2018-06-21Darren S ClineDirectorBuy20,468.0020,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918041868/0001104659-18-041868-index.htm
2019-03-12David GioncoChief Accounting OfficerSell530.0011.055,856.50224,938.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919015343/0001104659-19-015343-index.htm
2019-03-11David GioncoChief Accounting OfficerSell13,492.0011.11149,896.12225,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919015343/0001104659-19-015343-index.htm
2018-09-12Ivan BergsteinChief Executive OfficerBuy125,000.002,281,431.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918056985/0001104659-18-056985-index.htm
2019-12-27David GioncoChief Accounting OfficerSell197.0010.482,064.56235,421.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000979/0001104659-20-000979-index.htm
2019-12-26David GioncoChief Accounting OfficerSell1,511.0010.7516,243.25235,618.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000979/0001104659-20-000979-index.htm
2019-12-24David GioncoChief Accounting OfficerSell2,388.0010.9726,196.36237,129.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000979/0001104659-20-000979-index.htm
2019-03-07David GioncoChief Accounting OfficerSell1,381.0011.3215,632.92238,960.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919013683/0001104659-19-013683-index.htm
2019-12-23David GioncoChief Accounting OfficerSell421.0010.584,454.18239,517.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000979/0001104659-20-000979-index.htm
2019-02-06David GioncoChief Accounting OfficerBuy69,550.00239,895.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006896/0001104659-19-006896-index.htm
2019-05-03David GioncoChief Accounting OfficerBuy15,000.00239,938.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919030358/0001104659-19-030358-index.htm
2019-02-25David GioncoChief Accounting OfficerSell8,563.0012.03103,012.89240,341.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919011258/0001104659-19-011258-index.htm
2018-09-12Ivan BergsteinChief Executive OfficerBuy200,000.002,481,431.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918056985/0001104659-18-056985-index.htm
2019-02-06David GioncoChief Accounting OfficerBuy9,009.00248,904.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006896/0001104659-19-006896-index.htm
2019-12-27Ivan BergsteinChief Executive OfficerSell2,446.0010.4825,634.082,514,773.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000978/0001104659-20-000978-index.htm
2019-12-26Ivan BergsteinChief Executive OfficerSell18,744.0010.75201,498.002,517,219.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000978/0001104659-20-000978-index.htm
2019-12-24Ivan BergsteinChief Executive OfficerSell29,613.0010.97324,854.612,535,963.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000978/0001104659-20-000978-index.htm
2019-12-23Ivan BergsteinChief Executive OfficerSell5,225.0010.5855,280.502,565,576.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000978/0001104659-20-000978-index.htm
2019-08-14Ivan BergsteinChief Executive OfficerSell35,010.0014.73515,697.302,570,801.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919046425/0001104659-19-046425-index.htm
2019-06-26Ivan BergsteinChief Executive OfficerSell16,994.0014.77251,001.382,605,811.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038309/0001104659-19-038309-index.htm
2019-06-25Ivan BergsteinChief Executive OfficerSell28,500.0015.10430,350.002,622,805.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038309/0001104659-19-038309-index.htm
2019-06-24Ivan BergsteinChief Executive OfficerSell10,822.0015.49167,632.782,651,305.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038309/0001104659-19-038309-index.htm
2019-03-12Ivan BergsteinChief Executive OfficerSell2,151.0011.0523,768.552,662,127.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919015345/0001104659-19-015345-index.htm
2019-03-11Ivan BergsteinChief Executive OfficerSell55,073.0011.11611,861.032,664,278.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919015345/0001104659-19-015345-index.htm
2019-03-07Ivan BergsteinChief Executive OfficerSell6,800.0011.4177,588.002,719,351.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919013682/0001104659-19-013682-index.htm
2019-02-25Ivan BergsteinChief Executive OfficerSell22,905.0012.03275,547.152,726,151.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919011256/0001104659-19-011256-index.htm
2019-02-14Ivan BergsteinChief Executive OfficerSell34,132.0010.98374,769.362,749,056.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919009112/0001104659-19-009112-index.htm
2019-02-06Ivan BergsteinChief Executive OfficerBuy284,748.002,766,179.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006897/0001104659-19-006897-index.htm
2019-02-06Ivan BergsteinChief Executive OfficerBuy17,009.002,783,188.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006897/0001104659-19-006897-index.htm
2020-04-15Ivan BergsteinChief Executive OfficerSell53,618.004.88261,655.842,804,336.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920048399/0001104659-20-048399-index.htm
2018-06-21Alan S FormanDirectorBuy13,158.0028,158.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918041869/0001104659-18-041869-index.htm
2020-04-01David GioncoChief Accounting OfficerSell11,524.004.7955,199.96282,878.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920043324/0001104659-20-043324-index.htm
2020-03-10Ivan BergsteinChief Executive OfficerSell36,542.004.92179,786.642,857,954.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033489/0001104659-20-033489-index.htm
2020-03-09Ivan BergsteinChief Executive OfficerSell20,909.005.09106,426.812,894,496.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033489/0001104659-20-033489-index.htm
2020-02-25Ivan BergsteinChief Executive OfficerSell24,642.006.42158,201.642,915,405.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920027398/0001104659-20-027398-index.htm
2020-02-10Ivan BergsteinChief Executive OfficerBuy425,274.002,940,047.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920022137/0001104659-20-022137-index.htm
2020-06-10Ivan BergsteinChief Executive OfficerBuy220,000.003,024,336.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920071837/0001104659-20-071837-index.htm
2020-03-16David GioncoChief Accounting OfficerSell2,849.003.8811,054.12316,885.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920037012/0001104659-20-037012-index.htm
2020-03-10David GioncoChief Accounting OfficerSell8,846.004.9243,522.32319,734.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033488/0001104659-20-033488-index.htm
2020-06-10David GioncoChief Accounting OfficerBuy45,000.00327,878.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920071841/0001104659-20-071841-index.htm
2020-03-09David GioncoChief Accounting OfficerSell5,011.005.0825,455.88328,580.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033488/0001104659-20-033488-index.htm
2020-02-25David GioncoChief Accounting OfficerSell9,147.006.4358,815.21333,591.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920027399/0001104659-20-027399-index.htm
2020-02-10David GioncoChief Accounting OfficerBuy107,317.00342,738.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920022138/0001104659-20-022138-index.htm
2019-06-25DANIEL HUMEDirectorBuy15,000.0035,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038308/0001104659-19-038308-index.htm
2019-06-25Darren S ClineDirectorBuy15,000.0035,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038307/0001104659-19-038307-index.htm
2018-06-21Mark SardDirectorBuy20,468.0036,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918041871/0001104659-18-041871-index.htm
2018-06-21RON BENTSURDirectorBuy13,158.0040,443.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918041867/0001104659-18-041867-index.htm
2019-06-25Alan S FormanDirectorBuy15,000.0043,158.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038303/0001104659-19-038303-index.htm
2018-06-21KENNETH J ZUERBLISDirectorBuy13,158.0045,121.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918041872/0001104659-18-041872-index.htm
2018-09-12Kenneth HobermanChief Operating OfficerBuy100,000.00511,034.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918056986/0001104659-18-056986-index.htm
2019-06-25Mark SardDirectorBuy15,000.0051,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038306/0001104659-19-038306-index.htm
2019-06-25RON BENTSURDirectorBuy15,000.0055,443.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038302/0001104659-19-038302-index.htm
2020-01-22Kenneth HobermanChief Operating OfficerSell22,139.007.02155,415.78601,085.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920006882/0001104659-20-006882-index.htm
2019-06-25KENNETH J ZUERBLISDirectorBuy15,000.0060,121.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038305/0001104659-19-038305-index.htm
2020-01-08Kenneth HobermanChief Operating OfficerSell13,228.0010.37137,174.36623,224.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920003149/0001104659-20-003149-index.htm
2019-12-27Kenneth HobermanChief Operating OfficerSell2,022.0010.4821,190.56636,452.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/0001104659-20-000980-index.htm
2019-12-26Kenneth HobermanChief Operating OfficerSell15,494.0010.75166,560.50638,474.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/0001104659-20-000980-index.htm
2019-01-08Kenneth HobermanChief Operating OfficerSell13,547.0010.15137,502.05646,652.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919001650/0001104659-19-001650-index.htm
2019-12-24Kenneth HobermanChief Operating OfficerSell24,477.0010.97268,512.69653,968.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/0001104659-20-000980-index.htm
2019-06-25RON BENTSURDirectorBuy10,000.0065,443.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038302/0001104659-19-038302-index.htm
2018-11-26Kenneth HobermanChief Operating OfficerSell26,296.0011.85311,607.60659,738.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918070899/0001104659-18-070899-index.htm
2019-12-23Kenneth HobermanChief Operating OfficerSell4,319.0010.5845,695.02678,445.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/0001104659-20-000980-index.htm
2019-06-26Kenneth HobermanChief Operating OfficerSell12,508.0014.77184,743.16682,764.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/0001104659-19-038310-index.htm
2018-09-12Kenneth HobermanChief Operating OfficerBuy175,000.00686,034.00https://www.sec.gov/Archives/edgar/data/1264587/000110465918056986/0001104659-18-056986-index.htm
2019-06-25Kenneth HobermanChief Operating OfficerSell25,500.0015.07384,285.00695,272.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/0001104659-19-038310-index.htm
2019-06-24Kenneth HobermanChief Operating OfficerSell9,107.0015.49141,067.43720,772.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/0001104659-19-038310-index.htm
2019-05-14Kenneth HobermanChief Operating OfficerSell25,817.0014.27368,408.59729,879.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919030357/0001104659-19-030357-index.htm
2019-03-12Kenneth HobermanChief Operating OfficerSell981.0011.0410,830.24755,696.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919015344/0001104659-19-015344-index.htm
2019-03-11Kenneth HobermanChief Operating OfficerSell25,101.0011.11278,872.11756,677.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919015344/0001104659-19-015344-index.htm
2020-03-10Kenneth HobermanChief Operating OfficerSell16,704.004.9182,016.64771,764.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033491/0001104659-20-033491-index.htm
2019-02-06Kenneth HobermanChief Operating OfficerBuy135,071.00781,723.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006898/0001104659-19-006898-index.htm
2019-03-07Kenneth HobermanChief Operating OfficerSell2,995.0011.3634,023.20781,778.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919013684/0001104659-19-013684-index.htm
2019-02-25Kenneth HobermanChief Operating OfficerSell10,557.0012.05127,211.85784,773.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919011257/0001104659-19-011257-index.htm
2020-03-09Kenneth HobermanChief Operating OfficerSell9,487.005.0848,193.96788,468.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920033491/0001104659-20-033491-index.htm
2019-02-06Kenneth HobermanChief Operating OfficerBuy13,607.00795,330.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919006898/0001104659-19-006898-index.htm
2020-02-25Kenneth HobermanChief Operating OfficerSell11,547.006.4274,131.74797,955.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920027397/0001104659-20-027397-index.htm
2020-02-10Kenneth HobermanChief Operating OfficerBuy208,417.00809,502.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920022140/0001104659-20-022140-index.htm
2019-12-02Alan S FormanDirectorBuy1,000.0010.2910,290.0087,298.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919070016/0001104659-19-070016-index.htm
2019-12-04Alan S FormanDirectorBuy1,000.009.739,730.0088,298.00https://www.sec.gov/Archives/edgar/data/1264587/000110465919070740/0001104659-19-070740-index.htm
2020-02-07Robert FrancomanoChief Commercial OfficerSell5,064.006.7234,030.0893,257.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920022139/0001104659-20-022139-index.htm
2019-12-27Robert FrancomanoChief Commercial OfficerSell116.0010.481,215.6898,321.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000976/0001104659-20-000976-index.htm
2019-12-26Robert FrancomanoChief Commercial OfficerSell893.0010.759,599.7598,437.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000976/0001104659-20-000976-index.htm
2019-12-24Robert FrancomanoChief Commercial OfficerSell1,412.0010.9715,489.6499,330.00https://www.sec.gov/Archives/edgar/data/1264587/000110465920000976/0001104659-20-000976-index.htm